Instant search results.

These results are sorted by relevance. You can sort the results by clicking on the table headers.

Entry ID	Original Release date	Data summary	Entry Title	Citation Title	Authors
52316	2024-07-22	Chemical Shifts: 1 set	Vcom2	Isolation and Characterization of Insecticidal Cyclotides from Viola communis	Conan K Wang, David J Craik, Edward K Gilding, Negin Khatibi, Thomas Durek, Yen-Hua Huang
52314	2024-09-24	Chemical Shifts: 1 set	Ancy-m, Ancestral Mobius cyclotide	Structure and Activity of Reconstructed Pseudo-Ancestral Cyclotides	Conan K Wang, David J Craik, Quentin Kaas, Yen-Hua Huang, Zhihao Jiang
52313	2024-07-22	Chemical Shifts: 1 set	Vcom1	Isolation and Characterization of Insecticidal Cyclotides from Viola communis	Conan K Wang, David J Craik, Edward K Gilding, Negin Khatibi, Thomas Durek, Yen-Hua Huang
52315	2024-09-24	Chemical Shifts: 1 set	Ancy-b, Ancestral Bracelet cyclotide	Structure and Activity of Reconstructed Pseudo-Ancestral Cyclotides	Conan K Wang, David J Craik, Quentin Kaas, Yen-Hua Huang, Zhihao Jiang
31102	2024-03-08	Chemical Shifts: 1 set	NMR structure of L5pG ([p23W, G24W]kalata B1)	Nucleation of a key beta-turn promotes cyclotide oxidative folding	Conan K Wang, David J Craik, Simon J de Veer, Sixin Tian, Thomas Durek
30938	2022-02-25	Chemical Shifts: 1 set Spectral_peak_list: 1 set	hyen D solution structure	Mutagenesis of bracelet cyclotide hyen D reveals functionally and structurally critical residues for membrane binding and cytotoxicity	Conan K Wang, David J Craik, Qingdan Du, Quentin Kaas, Yen-Hua H Huang
50567	2020-11-24	Chemical Shifts: 1 set	Structure of PCSK9 antagonist P9-38	Bioactive cyclization optimizes the affinity of a proprotein convertase subtilisin/kexin type 9 (PCSK9) peptide inhibitor	Benjamin J Tombling, Carmen Lammi, Conan K Wang, David J Craik, Edward K Gilding, Giovanni Grazioso, Nicole Lawrence
50315	2020-07-09	Chemical Shifts: 1 set	ABD	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50316	2020-07-09	Chemical Shifts: 1 set	ABD12	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50317	2020-07-09	Chemical Shifts: 1 set	ABD23	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50318	2020-07-09	Chemical Shifts: 1 set	ABD1	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50319	2020-07-09	Chemical Shifts: 1 set	ABD2	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50320	2020-07-09	Chemical Shifts: 1 set	ABD3	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50321	2020-07-09	Chemical Shifts: 1 set	ABD2'	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50322	2020-07-09	Chemical Shifts: 1 set	ABD23ss	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
50323	2020-07-09	Chemical Shifts: 1 set	ABD23ac	Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery	Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann
30666	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of SFTI-R10	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30667	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of SFTI1 based KLK7 protease inhibitor	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30670	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of a triazole bridged KLK7 inhibitor	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30671	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of triazole bridged plasmin inhibitor	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30668	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of SFTI-1 based plasmin inhibitor	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30669	2020-04-16	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of triazole bridged matriptase inhibitor	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
30654	2020-06-26	Chemical Shifts: 1 set Spectral_peak_list: 1 set	NMR solution structure of triazole bridged SFTI-1	Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides	Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek
19176	2014-02-03	Chemical Shifts: 1 set	[Asp11]RTD-1	The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif	Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar
19177	2014-02-03	Chemical Shifts: 1 set	[Asp2,11]RTD-1	The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif	Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar
19175	2014-02-03	Chemical Shifts: 1 set	[Asp2]RTD-1	The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif	Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar
16074	2009-09-04	Chemical Shifts: 1 set	Solution structure of micelle-bound kalata B2	Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes	Conan K Wang, David C Ireland, David J Craik, Michelle L Colgrave, Quentin Kaas
16073	2009-09-04	Chemical Shifts: 1 set	Solution structure of cycloviolacin O2	Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes	Conan K Wang, David C Ireland, David J Craik, Michelle L Colgrave, Quentin Kaas